Although the use of fertility drugs for ovulation induction increases the risk of multiple pregnancy, appropriate administration and monitoring can greatly minimise these risks. Protocols should be in place which emphasise the importance of adhering to prescribed dosage and treatment plans. Patients should also be aware that in the event that too many follicles develop, the treatment cycle may be cancelled.
When anti-oestrogens are prescribed, patients must be given written and verbal information about the link between the drug/dose and the risks of multiple pregnancy. The minimum dosage should be used and cycles monitored using ultrasound.
More about anti-oestrogen drugs>>
Appropriate treatment with hormones should include targeting suitable patients, giving them information about the link between the drugs and the risks of multiple pregnancy and offering appropriate monitoring.
More about hormone treatment>>